Copyright
©The Author(s) 2018.
World J Transplantation. Nov 30, 2018; 8(7): 252-261
Published online Nov 30, 2018. doi: 10.5500/wjt.v8.i7.252
Published online Nov 30, 2018. doi: 10.5500/wjt.v8.i7.252
Figure 1 Outcome of post hematopoietic stem cell transplant for high risk acute lymphoblastic leukemia/lymphoma.
A: Cumulative incidence of relapse; B: Cumulative incidence of non-relapse mortality; C: Progression free survival; D: Overall survival. PFS: Progression free survival; OS: Overall survival; CI: Cumulative incidence.
Figure 2 Overall survival of high risk acute lymphoblastic leukemia.
A: Stratified by remission status prior to transplantation; B: Stratified by chronic graft vs host disease status HCT: Hematopoietic stem cell transplant; OS: Overall survival; cGVHD: Chronic graft vs host disease.
- Citation: Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplantation 2018; 8(7): 252-261
- URL: https://www.wjgnet.com/2220-3230/full/v8/i7/252.htm
- DOI: https://dx.doi.org/10.5500/wjt.v8.i7.252